Related Experiment Videos
Soretolide (Laboratoires Biocodex)
1Sultan Quaboos University, Chemistry Dept College of Science, Ai-Khod, Sultanate of Oman. majek@squ.edu.om
Current Opinion in Investigational Drugs (London, England : 2000)
|September 27, 2001
Summary
Soretolide is an experimental epilepsy drug showing anticonvulsant properties in animal models, similar to carbamazepine. Further development plans for this potential epilepsy treatment are under discussion.
Area of Science:
- Neuroscience
- Pharmacology
Background:
- Epilepsy is a neurological disorder characterized by recurrent seizures.
- Current antiepileptic drugs have limitations, necessitating the development of novel treatments.
Purpose of the Study:
- To evaluate the anticonvulsant profile of soretolide (D-2916) in preclinical models.
- To compare the efficacy of soretolide with a known antiepileptic drug, carbamazepine.
Main Methods:
- Soretolide was tested in animal models of epilepsy, specifically the maximal electroshock test and pentylenetetrazole-induced seizures.
- The anticonvulsant activity of soretolide was compared to that of carbamazepine.
Main Results:
- Soretolide demonstrated an anticonvulsant profile in animal models.
- Its activity was comparable to carbamazepine in the maximal electroshock test.
- Soretolide showed limited activity against pentylenetetrazole-induced seizures.
Conclusions:
- Soretolide exhibits potential as an antiepileptic agent.
- Further clinical investigation in Phase II trials is ongoing.
- Future development strategies for soretolide are being considered by Laboratoires Biocodex.